Surge Health is an independent sponsor focused on acquiring & growing lower & middle market companies, with a primary interest in healthcare and secondary interests in business services and technology-enabled businesses. We are located in New York with portfolio companies in the United States.
We are primarily interested in enabling growth of important and long-standing American businesses to expand reach.
We look for management teams interested in a growth partner, but will also work with businesses where founders are seeking an exit or business sale.
We bring first-hand operational experience across all business functions across the healthcare industry.
On day 1 of our partnership, our team will have a customized operational playbook, based on experience, to preserve key elements of your business while establishing necessary infrastructure that will enable national scale.
We have experience in non-clinical and clinical healthcare services, medical technologies, recruiting and staffing, data and software applications, clinical research, and business services.
We focus on a small number of high-quality and thesis-driven opportunities where we are confident in our ability to add value & enable growth.
Our team takes a customized approach to each opportunity, enabling creative deal structures and outcomes.
Our team has prior acquisition experience and a track record of closing transactions. With us you can feel confident in working with an experienced partner who will do right by you, your company, and your legacy.
While we specialize in the healthcare industry, we do have experience in business services, technology, and education.
Within the healthcare industry, we have a particular interest in non-clinical healthcare services, clinical trials businesses, payor services, and technology-enabled businesses.
We are able to offer the most value to businesses with at least $1M in EBITDA and/or greater than $3M in revenue.
Parth Sheth is the Founder & President of Surge Health LLC, which started in 2018 as a strategy consultancy for healthcare companies. He helped medical device and digital health companies in product development and commercialization of innovative technologies in medical imaging, behavioral health, emergency medicine, and cardiology. He also provided investment analysis for venture and investment teams at hospitals including the Children’s Hospital of Philadelphia (CHOP).
Surge Health acquired and currently owns a healthcare consulting business based in Florida.
Prior to starting Surge Health LLC, Parth served his country as an analyst at the Central Intelligence Agency (CIA). Parth has also consulted for several MSOs and DSOs of all sizes across the country and across several medical specialties.
He previously worked in the biomedical research setting on projects developing artificial lungs and hearts as well as artificial intelligence software that detect and diagnose prostate cancer. He is a co-author on peer-reviewed, scientific publications describing this work in Critical Care Medicine and The Annals of Thoracic Surgery.
Parth’s educational background includes an MBA in management and finance from Columbia University, an MS in biomedical engineering from the Johns Hopkins University, and a BS in biomedical engineering from the University of Michigan. Parth was born and raised in New Jersey.
